Theravance Biopharma, Inc.TBPHNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, structural decline.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-11.87M
↑ 92% above average
Average (9y)
$-153.48M
Historical baseline
Range
High:$-11.87M
Low:$-257.02M
CAGR
-25.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-11.87M | +59.8% |
| 2023 | $-29.48M | +84.3% |
| 2022 | $-187.56M | +11.2% |
| 2021 | $-211.26M | +17.8% |
| 2020 | $-257.02M | -6.5% |
| 2019 | $-241.37M | -101.0% |
| 2018 | $-120.11M | +41.0% |
| 2017 | $-203.46M | -101.2% |
| 2016 | $-101.12M | +41.0% |
| 2015 | $-171.50M | - |